Ranbaxy Forex Derivative Loss 25 Billion Rupees : Economictimes com

RANBAXY LABORATORIES LTD DOWN 3.4 PCT ON AN ECONOMIC TIMES NEWSPAPER REPORT THAT THE DRUG MAKER COULD BE SITTING ON MARK-TO-MARKET LOSSES OF OVER 25 BILLION RUPEES ($503 MILLION) ON FOREIGN CURRENCY DERIVATIVES TRANSACTIONS